Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (1351-1360 of 1,467) with videos related to

Pageof 147
Sort By:
Annals of the Rheumatic Diseases|April 24, 2026
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025Kevin L Winthrop, Andreas Kerschbaumer, John D Isaacs, et al.
RMD Open|May 6, 2022
Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countriesFlorian Lucasson, Uta Kiltz, Umut Kalyoncu, et al.
Nature Medicine|March 5, 2002
Autoantigen microarrays for multiplex characterization of autoantibody responsesWilliam H Robinson, Carla DiGennaro, Wolfgang Hueber, et al.
Annals of the Rheumatic Diseases|July 1, 2018
Non-classical monocytes as mediators of tissue destruction in arthritisAntonia Puchner, Victoria Saferding, Michael Bonelli, et al.
Lupus|March 13, 2001
Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluationA J Swaak, H G van den Brink, R J Smeenk, et al.
Seminars in Arthritis and Rheumatism|July 19, 2021
Considerations and priorities for incorporating the patient perspective on remission in rheumatoid arthritis: An OMERACT 2020 special interest group reportBethan Jones, Caroline A Flurey, Susanna Proudman, et al.
Annals of the Rheumatic Diseases|November 17, 2018
Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countriesClémence Gorlier, Ana-Maria Orbai, Déborah Puyraimond-Zemmour, et al.
Annals of the Rheumatic Diseases|September 16, 2008
Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritisT Karonitsch, D Aletaha, M Boers, et al.
Annals of the Rheumatic Diseases|May 3, 2014
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiativeLaure Gossec, Maarten de Wit, Uta Kiltz, et al.
Rheumatology (Oxford, England)|January 3, 2025
Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP studyClementina López-Medina, Clémence Gorlier, Ana-Maria Orbai, et al.
Pageof 147

Showing results (1351-1360 of 1,467) with videos related to

Sort By:
Pageof 147
Annals of the Rheumatic Diseases|April 24, 2026
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025Kevin L Winthrop, Andreas Kerschbaumer, John D Isaacs, et al.
RMD Open|May 6, 2022
Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countriesFlorian Lucasson, Uta Kiltz, Umut Kalyoncu, et al.
Nature Medicine|March 5, 2002
Autoantigen microarrays for multiplex characterization of autoantibody responsesWilliam H Robinson, Carla DiGennaro, Wolfgang Hueber, et al.
Annals of the Rheumatic Diseases|July 1, 2018
Non-classical monocytes as mediators of tissue destruction in arthritisAntonia Puchner, Victoria Saferding, Michael Bonelli, et al.
Lupus|March 13, 2001
Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluationA J Swaak, H G van den Brink, R J Smeenk, et al.
Seminars in Arthritis and Rheumatism|July 19, 2021
Considerations and priorities for incorporating the patient perspective on remission in rheumatoid arthritis: An OMERACT 2020 special interest group reportBethan Jones, Caroline A Flurey, Susanna Proudman, et al.
Annals of the Rheumatic Diseases|November 17, 2018
Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countriesClémence Gorlier, Ana-Maria Orbai, Déborah Puyraimond-Zemmour, et al.
Annals of the Rheumatic Diseases|September 16, 2008
Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritisT Karonitsch, D Aletaha, M Boers, et al.
Annals of the Rheumatic Diseases|May 3, 2014
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiativeLaure Gossec, Maarten de Wit, Uta Kiltz, et al.
Rheumatology (Oxford, England)|January 3, 2025
Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP studyClementina López-Medina, Clémence Gorlier, Ana-Maria Orbai, et al.
Pageof 147